-1.9 (-0.61%)
-3.1 (-0.99%) 3.32 pm | 08 May 2012 | Source: Reuters
Generic drugmaker Cipla is looking into cutting prices of more cancer drugs after it slashed the prices last week of three treatments by up to 75%, YK...
1.02 pm | 04 May 2012 | Source: Moneycontrol.com
Cipla's shocking 75% price cut of three cancer drugs on Thursday is unlikely to have a major impact on its earnings, analysts say....
5.00 pm | 03 May 2012 | Source: Reuters
Cipla has cut the price of the generic version of Bayer's renal cancer drug Nexavar by 75 percent and will sell it at 6,840 rupees for a monthly dose,...